Frédéric Caux
Frédéric Caux is an expert in Dermatology at Hôpital Avicenne (France). As of October 2026, ScienceLeadR ranks Frédéric Caux in the top 1% of experts worldwide for Skin Diseases, Vesiculobullous. Frédéric Caux has authored 323 publications, the most recent in 2026, and is an investigator in 9 clinical trials, 2 of them ongoing. SLR score: 805 (community average: 125). How the SLR is computed.
LeadR Profile
Dermatology
Subspecialties: Immunology - Genetics - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1990 - 2026
Number : 323
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Treatment of mild to moderate pemphigus with the use of rituximab and topical corticosteroids. PMID 42929667 — sexually transmitted diseases, adrenal cortex hormones, skin diseases, rituximab, therapeutics, pemphigus | J Eur Acad Dermatol Venereol | 2026 | 0 |
| Efficacy and safety of subcutaneous efgartigimod with prednisone in moderate-to-severe pemphigus (ADDRESS): a global, phase III, randomised controlled, double-blind trial. PMID 42723554 — syphilis, safety, prednisone, adrenal cortex hormones, desmogleins, therapeutics, pemphigus, dermatology | Br J Dermatol | 2026 | 0 |
| ERN GENTURIS cancer surveillance guideline for individuals with PTEN hamartoma tumour syndrome (PHTS). PMID 42463809 — skin, melanoma, neoplasms, multiple chronic conditions, thyroid gland, breast, colorectal neoplasms, genetics, medical, hamartoma | Eur J Hum Genet | 2026 | 1 |
| Genetic sequencing strategy for the diagnosis of epidermal differentiation disorders: A cohort study. PMID 42206543 — sexually transmitted diseases, whole genome sequencing, cohort studies, skin diseases, diagnosis | J Eur Acad Dermatol Venereol | 2026 | 0 |
| Combined Oral Ivermectin and 5% Permethrin Cream to Treat Severe Scabies. PMID 42090793 — skin, ivermectin, absenteeism, permethrin, scabies, therapeutics | N Engl J Med Top journal | 2026 | 0 |
Clinical Studies 9
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Cellular and Molecular Biomarkers in Patients With Lichen Planus NCT06451744 — skin, cells, epitopes, blood, biopsy, biomarkers, lichens, diagnosis, alphapapillomavirus, lichen planus, mucous membrane, wounds and injuries, membranes, human papillomavirus viruses | N/A | Recruiting | 2023 |
| Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus NCT05898308 — injections, skin, antibodies, adrenal cortex hormones, skin diseases, desmogleins, biomarkers, maintenance, rituximab, precision medicine, acantholysis, therapeutics, pemphigus | Phase 4 | Recruiting | 2024 |
LeadR Networks
Main global connection map